He said, “Nothing epitomized market failures more than the price of insulin. Many Americans spend $300 to $500 per month for this life-saving drug. California is now taking matters into our own hands.”
California will allocate $100 million to the project. Half of that will be used to develop low-cost insulin products. The other half is earmarked for a manufacturing facility in the state.
© 2024 KOBI-TV NBC5. All rights reserved unless otherwise stated.